HOME >> BIOLOGY >> NEWS
Gene responsible for developmental disorder identified

Researchers at Michigan State University have identified the gene responsible for a developmental disorder known as Smith-Magenis syndrome (SMS), a discovery that could lead to new therapies for the disorder and the myriad problems that accompany it.

The finding is documented in the March 24 issue of Nature Genetics, a prestigious peer-reviewed British journal.

SMS is a chromosome microdeletion syndrome that is characterized by a very distinct series of physical, developmental and behavioral features, including varying levels of mental retardation, cranio-facial abnormalities, sleep disturbances and self-injurious behaviors.

Because the disease is manifested in so many ways and is associated with a chromosomal deletion that includes many genes, it was always assumed that more than one gene contributed to the disorder, said researcher Sarah Elsea.

"This disorder was assumed to be a contiguous gene syndrome," said Elsea, an assistant professor in the departments of Pediatrics and Human Development and Zoology. "However, our data show that primarily one gene contributes to the phenotype."

What Elsea and colleagues found was mutation on a gene identified as retionic acid induced 1 (RAI1) that prevents the production of normal protein from that gene.

"The result of this mutation is that the protein can't be formed properly," she said. "Individuals with SMS have one normal functioning RAI1 protein from one chromosome, but from the other chromosome they are not getting this protein function at all."

Because SMS is a sporadic genetic disorder, prevention is pretty much out of the question, Elsea said. However, early diagnosis of the disorder can lead to improved outcomes.

"I think that in the future, if we understand what this gene, this protein, does and how it interacts with other proteins in the cell, we might be able to develop some kind of drug therapy that might help deal with the behaviors a li
'"/>

Contact: Tom Oswald
oswald@msu.edu
517-432-0920
Michigan State University
23-Mar-2003


Page: 1 2

Related biology news :

1. Scientists discover genetic marker responsible for two-fold increase in risk of rheumatoid arthritis
2. Possible link discovered between gene responsible for blood vessel development and ACD in newborns
3. Study of dyslexic brain finds three word forms responsible for reading success
4. Gene mutation responsible for Chrohns disease inflammation identified in Temple study
5. Researchers identify second gene responsible for rare syndrome associated with skeletal defects
6. Specific gene mutations responsible for congenital heart defects
7. Researchers develop guidelines to establish identity of genes responsible for complex diseases
8. Gene responsible for anemia (type CDA-1) discovered
9. Gene responsible for rewinding bodys clock described by scientists at TSRI
10. Researchers find mechanism responsible for neuronal death in prion diseases
11. Scientists discover genetic defect responsible for microcephaly

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/1/2020)... ... ... More than 600 people undergo genetic counseling and testing each year as ... two genetic counselors. , My Gene Counsel , a digital health company that ... Rick Program to ensure that UConn’s patients who have undergone genetic testing for cancer ...
(Date:4/30/2020)... ... April 29, 2020 , ... At ... growth – delivering innovative solutions for a wide range of industries including pharmaceutical ... agencies. A month into the new decade, it was clear to company leadership ...
(Date:4/26/2020)... ... April 23, 2020 , ... A team of researchers at the Icahn ... antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is intended ... treatment option for COVID-19. , The efforts are being led by Mone Zaidi, MD, ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... PARIS (PRWEB) , ... May 05, 2020 , ... ... appointing a high-profile CEO. Xavier Duburcq joins the group after 13 years at Altran, ... Chemicals. , Holding a PhD in Immunology and being a Pharmacist, Xavier was involved ...
(Date:4/22/2020)... Hungary and CAMBRIDGE, Mass. (PRWEB) , ... April ... ... in Budapest with US offices in Cambridge, MA, announced today that Omixon’s founder ... led the early commercialisation of Omixon’s flagship product Holotype HLA since 2014 before ...
(Date:4/7/2020)... , ... April 06, 2020 , ... ... solutions for the life sciences industry, has announced the release of at-home virtual ... our top priority is the health and safety of our employees as we ...
(Date:4/1/2020)... Conn. (PRWEB) , ... March 31, 2020 , ... ... Science, Inc. (P2) announce the signing of a Joint Development Agreement that ... , Bedoukian Research, Inc. is a global leader in the supply of high-quality ...
Breaking Biology Technology:
Cached News: